arrow
Back
N

Nancy L. Bartlett

thomas jefferson university

96H-index
935Paper Count
4.7WCitation Count
Published Papers 145
Publication Date
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
err2026-05-01
err1
PREAI
errOlszewski, Adam J.; Ollila, Thomas A.; Chihara, Dai; Shouse, Geoffrey; Grover, Natalie; Karmali, Reem; Torka, Pallawi; Thomas, Colin; Geethakumari, Praveen Ramakrishnan; Barta, Stefan K.; Bartlett, Nancy L.; Epperla, Narendranath
errShare
errSave
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma
errBlood
IF23.1
err2026-04-01
err2
PREAI
errAbramson, Jeremy S.; Straus, David J.; Bartlett, Nancy L.; Burke, John M.; Lynch, Ryan C.; Domenech, Eva Domingo; Hess, Brian; Schuster, Steven R.; Linhares, Yuliya; Gandhi, Mitul; Shah, Harsh R.; Jurczak, Wojciech; Re, Alessandro; Hahn, Uwe; Prince, H. Miles; Guo, Wenchuan; Davis, Griffith; Ho, Linda; Fanale, Michelle; Yasenchak, Christopher A.; Lee, Hun Ju
errShare
errSave
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma
err2026-03-23
err0
errOAAI
errGrace Baek; Gaurav Varma; Samuel Yamshon; Herman van Besien; Nancy L. Bartlett; Marcus Watkins; Harsh R. Shah; Kelsey Baron; Reid W. Merryman; Ayo S. Falade; Jakub Svoboda; Sara Prischak; Christopher D’Angelo; Joe D. Lukowski; Ranjana H. Advani; Austin H Yeung; Maya Rosenberg; Jenna Voutsinas; Mengyang Di; Ryan Lynch
errShare
errSave
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.
err2026-02-09
err0
errOAAI
errKatharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
errShare
errSave
B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines
err2025-10-01
err0
PREAI
errZelenetz, Andrew D.; Gordon, Leo I.; Abramson, Jeremy S.; Advani, Ranjana H.; Andreadis, Babis; Bartlett, Nancy L.; Budde, L. Elizabeth; Caimi, Paolo F.; Chang, Julie E.; Christian, Beth; DeVos, Sven; Dholaria, Bhagirathbhai; Fayad, Luis E.; Habermann, Thomas M.; Hamid, Muhammad Saad; Hernandez-Ilizaliturri, Francisco; Hu, Boyu; Karimi, Yasmin; Kelsey, Christopher R.; King, Rebecca; Kline, Justin; Krivacic, Susan; Lacasce, Ann S.; Landsburg, Daniel; Lim, Megan; Messmer, Marcus; Rabinovitch, Rachel; Ramakrishnan, Praveen; Reid, Erin; Roberts, Kenneth B.; Saeed, Hayder; Saito, Naoyuki G.; Smith, Stephen D.; Swinnen, Lode J.; Tuscano, Joseph; Vose, Julie M.; Dwyer, Mary; Sundar, Hema
errShare
errSave
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
err2025-08-21
err0
errOAAI
errSwaminathan Iyer; Neha Mehta-Shah; Ranjana Advani; Nancy L. Bartlett; Jacob H. Christensen; Franck Morschhauser; Eva Domingo-Domenech; Giuseppe Rossi; Won Seog Kim; Onder Alpdogan; Tatyana A. Feldman; Vincent Camus; Giuseppe Gritti; Pier Luigi Zinzani; David Belada; Jiri Mayer; Ilseung Choi; June-Won Cheong; Evelyn Rustia; Keenan Fenton
errShare
errSave
Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
err2025-08-19
err0
errOAAI
errAlex F. Herrera; Stephen M. Ansell; Pier Luigi Zinzani; John Radford; Kami Maddocks; Antonio Pinto; Graham P. Collins; Veronika Bachanova; Nancy L. Bartlett; Isabelle Bence-Bruckler; Mehdi Hamadani; Justin Kline; Jiří Mayer; Kerry J. Savage; Ranjana H. Advani; Paolo F. Caimi; René-Olivier Casasnovas; Tatyana Feldman; Brian Hess; Mariana Bastos-Oreiro
errShare
errSave
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
err2025-08-01
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results
err2025-05-05
err0
errOAAI
errBruce D. Cheson; Nancy L. Bartlett; Betsy Knopf; Hun J. Lee; Ranjana H. Advani; Beth Christian; Catherine S. Diefenbach; Tatyana A. Feldman; Stephen M. Ansell
errShare
errSave
Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
err2025-03-05
err0
errOAAI
errAjay K. Gopal; Philippe Armand; Sattva S. Neelapu; Nancy L. Bartlett; Stephen E. Spurgeon; John Kuruvilla; Kerry J. Savage; John P. Leonard; Arnold B. Gelb; Nasir Ahmed; Shiqi Dong; Sai Praneeth Bathena; Rasika Suryawanshi; Jenny Qun Wu; Sheen Wang; Douglas E. Gladstone
errShare
errSave
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma
err2024-11-28
err0
errOAAI
errFalchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel
errShare
errSave
Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errWagner-Johnston, Nina; Jegede, Opeyemi; Spurgeon, Stephen E.; Maddocks, Kami J.; Yang, David T.; Romanoff, Justin; Paludo, Jonas; Caimi, Paolo F.; Bartlett, Nancy L.; Reagan, Patrick M.; Sawalha, Yazeed; Hoffmann, Marc; Hu, Boyu; Aziz, Ashraf R.; Marques, Helga; Shields, Lale Kosakoglu; Leonard, John P.; Friedberg, Jonathan W.; Kahl, Brad S.
errShare
errSave
Long-Term Follow-up of Bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRyan, Christine E.; Nizamuddin, Imran A.; Raman, Hari S.; Redd, Robert A.; Watkins, Marcus P.; Lacasce, Ann S.; Fisher, David C.; Kim, Austin I.; Davids, Matthew S.; Jacobson, Caron A.; Odejide, Oreofe O.; Crombie, Jennifer L.; Mehta-Shah, Neha; Cashen, Amanda F.; Ghobadi, Armin; Bartlett, Nancy L.; Jacobsen, Eric D.; Armand, Philippe; Kahl, Brad S.; Merryman, Reid W.
errShare
errSave
Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBudde, Elizabeth; Matasar, Matthew; Sehn, Laurie H.; Assouline, Sarit E.; Kuruvilla, John; Flinn, Ian W.; Yoon, Sung-Soo; Bosch, Francesc; Greenwald, Daniel; Gutierrez, Norma C.; Tzachanis, Dimitrios; Marlton, Paula; Mcguirt, Delaney; Yin, Shen; Wei, Michael C.; Kwan, Antonia; Tracy, Samuel; Penuel, Elicia; Bartlett, Nancy L.
errShare
errSave
Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errDi Liberto, Maurizio; Hu, Yang; Huang, Xiangao; Inghirami, Giorgio; Wang, Kevin; Lee, Christina Y.; Maddocks, Kami J.; Blum, Kristie A.; Ruan, Jia; Leonard, John P.; Bartlett, Nancy L.; Martin, Peter; Elemento, Olivier; Chen-Kiang, Selina
errShare
errSave
Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errAlencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.
errShare
errSave
Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥ 2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errShadman, Mazyar; Bartlett, Nancy L.; Matasar, Matthew; Schuster, Stephen J.; Assouline, Sarit E.; Sehn, Laurie H.; Kuruvilla, John; Giri, Pratyush; Cheah, Chan Y.; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Wei, Michael C.; Yin, Shen; Ma, Connie Y.; Tracy, Samuel; Kwan, Antonia; Penuel, Elicia; Budde, L. Elizabeth
errShare
errSave
Trial in Progress- Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBeaven, Anne W.; Geyer, Susan M.; Cohen, Jonathon B.; Phillips, Tycel; Dockter, Travis; Pophali, Priyanka A.; Thanarajasingam, Gita; Mazza, Gina L.; Alencar, Alvaro J.; Dinner, Shira N.; Hsi, Eric D.; Welliver, Meng; Nikcevich, Daniel; Kahl, Brad S.; Friedberg, Jonathan W.; Bartlett, Nancy L.; Leonard, John P.
errShare
errSave